Contact UsQuotation
Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Proceed to checkoutContinue shopping
TOPBioactivityChemical infoStorage&SolubilityCalculator

PNU288034

Copy Product Info
😃Good
Catalog No. T12512Cas No. 383199-88-0

PNU288034, a potent oxazolidinone antibiotic, demonstrates antimicrobial activity for the prevention and treatment of Gram-negative infections.

PNU288034

PNU288034

Copy Product Info
😃Good
Purity: 98.41%
Catalog No. T12512Cas No. 383199-88-0
PNU288034, a potent oxazolidinone antibiotic, demonstrates antimicrobial activity for the prevention and treatment of Gram-negative infections.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$293-In Stock
5 mg$722-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products.If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:98.41%
ee:100%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

COA HNMR LCMS FNMR CSFC

Product Introduction

Bioactivity
Description
PNU288034, a potent oxazolidinone antibiotic, demonstrates antimicrobial activity for the prevention and treatment of Gram-negative infections.
In vitro
In vitro studies, conducted to characterize the involved transporters, demonstrate uptake of PNU-288034 by human organic anion transporter 3 (OAT3; Km = 44 +/- 5 μM) and human multidrug and toxin extrusion protein 1 (hMATE1; Km = 340 +/- 55 μM)[1].
In vivo
In liver microsomes across species, PNU-288034 exhibits metabolic stability, and the unchanged drug is cleared in the urine through an apparent active renal secretion process in rat and monkey. Coadministration of PNU-288034 with the OAT3 inhibitor probenecid significantly increases the plasma area under the curve (170%) and reduces both plasma and renal clearance in monkey. Furthermore, coadministration of PNU-288034 with cimetidine also reduces plasma clearance in rats to a rate comparable to probenecid coadministration[1].
Chemical Properties
Molecular Weight403.4
FormulaC16H19F2N3O5S
Cas No.383199-88-0
SmilesO=C1N(C[C@H](CNC(C)=O)O1)C2=CC(F)=C(C(F)=C2)N3CCS(=O)(=O)CC3
Relative Density.1.447 g/cm3 (Predicted)
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

PNU-288034PNU288034PNU 288034Fungal
Related Tags: buy PNU288034 | purchase PNU288034 | PNU288034 cost | order PNU288034 | PNU288034 chemical structure | PNU288034 in vivo | PNU288034 in vitro | PNU288034 formula | PNU288034 molecular weight
TargetMol | Logo

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.